Clinical trials
Phase 1/2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 4 |
| 2002 | 2 |
| 2004 | 6 |
| 2005 | 6 |
| 2006 | 6 |
| 2007 | 4 |
| 2008 | 6 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 8 |
| 2013 | 8 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 49 |
| Terminated | 12 |
| Withdrawn | 8 |
| Unknown status | 6 |
| Active, not recruiting | 4 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 10 |
| Novartis Pharmaceuticals | 6 |
| Fred Hutchinson Cancer Center | 5 |
| National Cancer Institute (NCI) | 4 |
| Bristol-Myers Squibb | 3 |
| Baylor College of Medicine | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| University of Michigan Rogel Cancer Center | 2 |
| Accenture | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 81 |
| Leukemia, Myeloid, Acute | 37 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 36 |
| Myelodysplastic Syndromes | 33 |
| Leukemia | 24 |
| Lymphoma, Non-Hodgkin | 16 |
| Hodgkin Disease | 14 |
| Blast Crisis | 13 |
| Multiple Myeloma | 13 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 11 |
Trials
Showing 76 to 81 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.